Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS)
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Authors: R.L. Jones, V. Ravi, A.S. Brohl, S.P. Chawla, K. Ganjoo, A. Italiano, S. Attia, M. Burgess, K. Thornton, L. Cranmer, L. Liu, C. Theuer, R. Maki
Institutions: Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Sarcoma Oncology Center, Stanford University, Institut Bergonié, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), University of Pittsburgh Medical Center, Dana-Farber Cancer Institute, University of Washington, Tracon Pharmaceuticals (United States), Northwell Health, Cold Spring Harbor Laboratory
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2979100319